Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Sensation Disorders » Somatosensory Disorders » Hyperalgesia
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Sensation Disorders » Somatosensory Disorders » Hyperalgesia
Description
An increased sensation of pain or discomfort produced by minimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve. MeSH
Hierarchy View
Phase 4 Indicated Drugs (17)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (10)
Other Experimental Indicated Drugs (13)
Organization Involved with Phase 4 Indications (30)
National Institute of General Medical Sciences (NIGMS)
National Institute on Drug Abuse (NIDA)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (22)
Organization Involved with Phase 1 Indications (15)
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
